awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36651931-F5255639-59B6-4E6F-B626-301E132DA598
Q36651931-F5255639-59B6-4E6F-B626-301E132DA598
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36651931-F5255639-59B6-4E6F-B626-301E132DA598
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy.
P2860
Q36651931-F5255639-59B6-4E6F-B626-301E132DA598
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36651931-F5255639-59B6-4E6F-B626-301E132DA598
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
807201c996e9952401e25a85ced234f2677c202a
P2860
[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1